Literature DB >> 12403838

Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus.

Maoqing Dong1, Mengwei Zang, Delia I Pinon, Zhijun Li, Terry P Lybrand, Laurence J Miller.   

Abstract

The amino terminus of the secretin receptor (SecR) is known to be critical for natural agonist action, although the role it plays is still unclear. We have demonstrated that photolabile residues within both the amino-terminal (position 6) and carboxyl-terminal (positions 22 and 26) halves of secretin each covalently label receptor amino-terminal tail residues [Dong et al., J Biol Chem, 274:19161-19167 (1999), 274:903-909 (1999), and 275:26032-26039 (2000)]. Here, we extend this series of studies with an additional probe having its site of covalent attachment in a distinct region of the peptide, between amino- and carboxyl-terminal helical domains. This probe incorporated a photolabile (epsilon-p-benzoylbenzoyl)lysine in position 18 and a site for oxidative radioiodination [(tyrosine(10),(benzoyl-benzoyl)lysine(18))rat secretin-27]. This analog represented a full agonist, stimulating cAMP accumulation in Chinese hamster ovary-SecR cells in a concentration-dependent manner. It bound to the SecR specifically and saturably, and was able to efficiently label that molecule within its amino terminus. Sequential specific cleavage, purification, and sequencing demonstrated that this probe labeled receptor residue arginine(14), in the same subdomain as that labeled by previous probes. Consistent with the importance of this residue, alanine replacement mutagenesis (R14A) resulted in substantial reductions in the potency (127-fold) and binding affinity (400-fold) of secretin relative to its action at the wild-type receptor. We have been able to accommodate all four extant pairs of residue-residue approximations between divergent regions of the secretin pharmacophore and the first forty residues of the SecR into a credible molecular model of this interaction. Additional experimentally derived constraints will be necessary to determine the spatial positioning of this complex with the remainder of the SecR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403838     DOI: 10.1210/me.2002-0111

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

Review 1.  Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.

Authors:  M Dong; C Koole; D Wootten; P M Sexton; L J Miller
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.

Authors:  Maoqing Dong; Polo C-H Lam; Delia I Pinon; Patrick M Sexton; Ruben Abagyan; Laurence J Miller
Journal:  Mol Pharmacol       Date:  2008-05-08       Impact factor: 4.436

3.  Molecular basis of secretin docking to its intact receptor using multiple photolabile probes distributed throughout the pharmacophore.

Authors:  Maoqing Dong; Polo C-H Lam; Delia I Pinon; Keiko Hosohata; Andrew Orry; Patrick M Sexton; Ruben Abagyan; Laurence J Miller
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

4.  Insights into the impact of phenolic residue incorporation at each position along secretin for receptor binding and biological activity.

Authors:  Maoqing Dong; Delia I Pinon; Laurence J Miller
Journal:  Regul Pept       Date:  2012-11-08

5.  Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.

Authors:  Thomas Dean; Agnes Linglart; Matthew J Mahon; Murat Bastepe; Harald Jüppner; John T Potts; Thomas J Gardella
Journal:  Mol Endocrinol       Date:  2005-12-08

Review 6.  Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor.

Authors:  Laurence J Miller; Maoqing Dong; Kaleeckal G Harikumar
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Effects of pH and temperature on photoaffinity labeling of Family B G protein-coupled receptors.

Authors:  Maoqing Dong; Laurence J Miller
Journal:  Regul Pept       Date:  2009-05-18

Review 8.  Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors.

Authors:  Kelly J Culhane; Yuting Liu; Yingying Cai; Elsa C Y Yan
Journal:  Front Pharmacol       Date:  2015-11-05       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.